MNBTD
RETA

Moody National Bank Trust Division’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Moody National Bank Trust Division’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-88
Closed -$8K – 1036
2019
Q1 		$8K Buy
+88
New +$7.3K ﹤0.01% 693

Other funds holding RETA

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Moody National Bank Trust Division's RETA Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q2 2019, closing a stake of 88 shares — an estimated $8K sold.

Moody National Bank Trust Division first reported a position in RETA in Q1 2019 and held it in 1 quarter. The position peaked at $8K in Q1 2019. 158 funds tracked by Wall St. Rank hold RETA as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 88 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q2 2019, an estimated $8K.
  • Moody National Bank Trust Division first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2019 and held it in 1 quarter.
  • Moody National Bank Trust Division's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $8K in Q1 2019.
  • 158 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.